Germany sets a new digitalization strategy, further supporting the adoption of digital therapeutics in Europe’s largest healthcare market
Copenhagen, Denmark, March 28, 2023 – Brain+ A/S (Nasdaq First North: BRAINP)
· Germany represents a large market potential for Brain+’ digital dementia therapeutics · Brain+ is preparing for commercial introduction of its first digital dementia product, CST-Therapist Companion, in Germany in the 2[nd] quarter of 2023 · As an important healthcare reference country, Germany’s strong digitalization commitment sets the stage for a more rapid adoption of digital therapeutics across EuropeThis month the German Ministry of Health's shared its new healthcare digitalization strategy, "